/PRNewswire/ Avectas, a cell engineering technology business, is delighted to announce the appointment of Dr Justin McCue, as its new Chief Technology.
Press release content from PR Newswire. The AP news staff was not involved in its creation.
AVECTAS Appoints Daniel Castro as Chief Business Officer
January 11, 2021 GMT
DUBLIN, Jan. 11, 2021 /PRNewswire/ Avectas, a cell engineering company that has pioneered SOLUPORE®, a transformative non-viral cell engineering technology, to enable efficient and safe genetic modification of the next generation of cell therapies, announced today that Daniel Castro has been appointed as Chief Business Officer. In the newly created US-based role, Mr. Castro will lead Avectas’ corporate strategy and business development, reporting to Michael Maguire PhD, Avectas’ CEO.
Mr. Castro brings more than 25 years of healthcare and pharmaceutical industry experience, with a focus on commercialization strategy, business development and licensing. He joins Avectas from Mass General Brigham (“MGB”), a not-for-profit, integrated health care system and teaching affiliate of Harvard Medical School. Bas